Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Keppra (levetiracetam) - Important Safety Information from UCB as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
07/02/2011
Problem Or Issue:
Important Safety Information communication from USB (Pharma) Ireland Ltd: Potential for dosing error when using Keppra (levetiracetam) oral solution due to change in syringe graduation markings, and new presentations for infants and children younger than 4 years of age.
Important safety information - Keppra (levetiracetam)
« Back
Date Printed: 04/05/2024